IsoRay Story

<div class='circular--portrait' style='background:#FF6600;color: #FFFAFA;font-size:3em;'>ISR</div>
ISR -- USA Stock  

USD 1.91  0.12  6.70%

It looks like ElectroCore will continue to recover much faster as its share price surged up 5.59% today to IsoRay's 7.9365%. As many investors are getting excited about healthcare space, IsoRay and ElectroCore may be going in opposite directions. We are going to discuss some of the competitive aspects of both IsoRay and ElectroCore.
Published over three months ago
View all stories for IsoRay | View All Stories
Will IsoRay (NYSEMKT:ISR) retail investors shift to ElectroCore (NASDAQ:ECOR)?
By analyzing existing basic indicators between IsoRay and ElectroCore, you can compare the effects of market volatilities on both companies' prices and check if they can diversify away market risk if combined in one of your portfolios. You can also utilize pair trading strategies for matching a long position in ElectroCore with a short position in IsoRay. Check out our pair correlation module for more information.

Let's begin by analyzing the assets. The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. IsoRay has an asset utilization ratio of 51.49 percent. This connotes that the company is making $0.51 for each dollar of assets. An increasing asset utilization means that IsoRay Inc is more efficient with each dollar of assets it utilizes for everyday operations.
Out of tens of thousands of stocks, funds, and ETFs that trade on global exchanges each represent an individual company which you can analyze using comparative analysis. To determine which one of the two companies, such as IsoRay or ElectroCore is a better fit for your portfolio, analyzing a few basic fundamental indicators is a good first step.

How important is IsoRay's Liquidity

IsoRay financial leverage refers to using borrowed capital as a funding source to finance IsoRay Inc ongoing operations. It is usually used to expand the firm's asset base and generate returns on borrowed capital. IsoRay financial leverage is typically calculated by taking the company's all interest-bearing debt and dividing it by total capital. So the higher the debt-to-capital ratio (i.e., financial leverage), the riskier the company. Please check the breakdown between IsoRay's total debt and its cash.

Correlation Between IsoRay and ElectroCore

In general, stock analysis is a method for investors and traders to make individual buying and selling decisions. Stock correlation analysis is also essential because it can help investors realize that they may not be as diversified as they think. Risk management strategies are usually required to make sure all portfolios are properly aligned against their risk tolerance level. You can consider holding IsoRay together with similar or unrelated positions with a negative correlation. For example, you can also add ElectroCore to your portfolio. If ElectroCore is not perfectly correlated to IsoRay it will diversify some of the market risks out of the positively correlated stocks in your portfolio. However, the disadvantage of this sort of hedging is that it can potentially affect your investment returns throughout market cycles. When IsoRay for example, for example, performs excellent and delivers stable returns, the negatively correlated position you locked in as a hedge may drag your returns down. Please check pair correlation details between ISR and ECOR for more information.


Are you currently holding both IsoRay and ElectroCore in your portfolio? Please note if you are using this as a pair-trade strategy between IsoRay and ElectroCore, watch out for correlation discrepancy over time. Relying on the historical price correlations and assuming that it will not change may lead to short-term losses.

Breaking down IsoRay Indicators

Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include product or services discounts, promotions, as well as early payments on invoices or services rendered in advance.

Revenue Breakdown

Now, let's check IsoRay revenue. Based on the latest financial disclosure, IsoRay Inc reported 9.32 M of revenue. This is 99.88% lower than that of the Healthcare sector and 99.49% lower than that of the Medical Instruments & Supplies industry. The revenue for all United States stocks is 99.9% higher than that of the company. As for ElectroCore we see revenue of 2.84 M, which is 99.85% lower than that of the Medical Instruments & Supplies

1.8 B
ISR9.32 Million0.5
Sector1.84 Billion99.34
ECOR2.84 Million0.15

Another 3 percent spike for IsoRay

Latest total risk alpha indicator falls down to -0.42. Possible price gain? As of the 16th of September 2020, IsoRay retains the risk adjusted performance of (0.0336), and Market Risk Adjusted Performance of 0.8485. IsoRay technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Simply put, you can use this information to find out if the firm will indeed mirror its model of historical price patterns, or the prices will eventually revert. We were able to analyze nineteen technical drivers for IsoRay Inc, which can be compared to its competitors. Please check out IsoRay Inc standard deviation, value at risk, as well as the relationship between the Value At Risk and kurtosis to decide if IsoRay is priced fairly, providing market reflects its last-minute price of 0.68 per share. As IsoRay Inc is a penny stock we also advise to confirm its total risk alpha numbers.

Our Takeaway on IsoRay Investment

When is the right time to buy or sell IsoRay Inc? Buying stocks such as IsoRay isn't very hard. However, what challenging for most investors is doing it at the right time. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities, deliver winning trades and diversify portfolios on a daily bases. The inconsistency in the assessment between current IsoRay valuation and our trade advice on IsoRay is due to the recent market swings and your selection of investing horizon. Please use our equity advice module to run different scenarios to ensure your current risk level and investment horizon are fully reflective of your current investing preferences in regards to IsoRay.

About Contributor

This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Raphi Shpitalnik do not own shares of IsoRay Inc. Please refer to our Terms of Use for any information regarding our disclosure principles.

Would you like to provide feedback on the content of this article?

You can get in touch with us directly or send us a quick note via email to